Skip to main content

Table 3 shows the medications at discharge and during follow-up used by the patients in the different BMI subgroups

From: Prolonged and intensive medication use are associated with the obesity paradox after percutaneous coronary intervention: a systematic review and meta-analysis of 12 studies

Discharged and follow-up Medications

Normal weight patients

Overweight patients

Obese patients

Aspirin (%)

94.7

95.1

95.0

Clopidogrel (%)

82.4

83.1

83.2

Statin (%)

76.8

79.3

81.3

ACEI/ARBs (%)

55.8

65.2

68.8

Beta blocker (%)

70.4

72.1

73.8

  1. Abbreviations: ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker